Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by A Furlan
Epigenetic Modulation With Oral Histone Deacetylase (HDAC) Inhibitor as a New Treatment Option in JIA
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Related publications
Histone Deacetylase (HDAC)
Science-Business eXchange
Antibody Drug Conjugates (ADC) Charged With HDAC Inhibitor for Targeted Epigenetic Modulation
Chemical Science
Chemistry
Lysophosphatidic Acid Protects Cancer Cells From Histone Deacetylase (HDAC) Inhibitor-Induced Apoptosis Through Activation of HDAC
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Preclinical Validation of AR42, a Novel Histone Deacetylase Inhibitor, as Treatment for Vestibular Schwannomas
Laryngoscope
Otorhinolaryngology
Epigenetic Modulation With HDAC Inhibitor CG200745 Induces Anti-Proliferation in Non-Small Cell Lung Cancer Cells
PLoS ONE
Multidisciplinary
Histone Deacetylase (HDAC) Inhibitory and Antiproliferative Activities of Phenolic-Rich Extracts Derived From the Rhizome of Hydnophytum Formicarum Jack.: Sinapinic Acid Acts as HDAC Inhibitor
BMC Complementary and Alternative Medicine
Medicine
Alternative Medicine
Complementary
Host Histone Acetylation Unlocks HDAC Inhibitor Potential
Oncotarget
Oncology
Histone Deacetylase 8 as a Novel Therapeutic Target in Oral Squamous Cell Carcinoma
Oncology Reports
Medicine
Cancer Research
Oncology
New Insights Into the Treatment of Multiple Myeloma With Histone Deacetylase Inhibitors
Current Pharmaceutical Design
Drug Discovery
Pharmacology
